{"id":70711,"date":"2026-05-12T09:38:54","date_gmt":"2026-05-12T09:38:54","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70711"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"dsip","status":"publish","type":"product","link":"https:\/\/medsbase.com\/it\/product\/dsip\/","title":{"rendered":"DSIP"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Risposta rapida \u2014 Cos'\u00e8 il DSIP?<\/h3>\n<p style=\"margin: 0;\"><strong>DSIP<\/strong> (Delta Sleep-Inducing Peptide) is a 9-amino-acid neuropeptide first isolated from rabbit cerebral venous blood during electrical stimulation of thalamic sleep-promoting regions in 1977. In published studies it modulates sleep architecture \u2014 specifically slow-wave (delta) sleep \u2014 alongside documented effects on stress reactivity, withdrawal syndromes, and nociception. Supplied in 5\u00a0mg to 15\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Cosa ottieni con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/it\/reviews\/\">recensioni dei clienti<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ogni ordine \u00e8 coperto dalla nostra <a href=\"https:\/\/medsbase.com\/it\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica di Garanzia di Rispedizione<\/strong><\/a> \u2014 se il tuo pacco non arriva entro 20 giorni lavorativi, lo rispediamo.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifiche<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Dettaglio<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Numero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">62568-57-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formula Molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>35<\/sub>H<sub>48<\/sub>N<sub>10<\/sub>O<sub>15<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">848,81 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE, 9 amminoacidi; lineare, estremit\u00e0 non modificate)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvere liofilizzata (da bianca a biancastra)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Purezza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificato con HPLC, COA disponibile su richiesta)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Conservazione<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizzato: 2\u20138 \u00b0C (frigorifero) per lo stock di lavoro; \u221220 \u00b0C per lo stoccaggio a lungo termine di flaconcini non aperti. Ricostituito: 2\u20138 \u00b0C, utilizzare entro ~30 giorni. Proteggere dalla luce. Non congelare e scongelare la soluzione ricostituita.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e0<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Acqua batteriostatica (consigliata) o acqua sterile per finestre d'uso pi\u00f9 brevi<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Cos'\u00e8 il DSIP?<\/h2>\n<p><strong>DSIP<\/strong> (Delta Sleep-Inducing Peptide) is a 9-amino-acid linear neuropeptide first isolated by Schoenenberger and Monnier at the University of Basel in 1977. The peptide was identified by dialysing cerebral venous blood from rabbits during electrical stimulation of the intralaminar thalamus \u2014 a region known to drive delta-wave (slow-wave) sleep in the cortex \u2014 and concentrating the bioactive fraction. DSIP was named for the dominant electroencephalographic signature it produced when administered to recipient animals: increased proportion of delta-wave activity during sleep. The well-characterised sequence is WAGGDASGE, molecular weight 848.81\u00a0Da, empirical formula C<sub>35<\/sub>H<sub>48<\/sub>N<sub>10<\/sub>O<sub>15<\/sub>. Il DSIP \u00e8 strutturalmente insolito tra i piccoli peptidi attivi nel SNC \u2014 \u00e8 lineare, non modificato a entrambe le estremit\u00e0 e non contiene residui di prolina o cisteina. Il peptide \u00e8 fornito come polvere liofilizzata ad alta purezza per ricostituzione con acqua batteriostatica. Il DSIP non \u00e8 approvato <strong>dalla FDA, EMA, MHRA o da qualsiasi altro importante regolatore per uso terapeutico umano. Il DSIP di grado di ricerca venduto qui \u00e8 fornito<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. For related circadian and sleep-axis peptide studies, see our <a href=\"https:\/\/medsbase.com\/it\/epitalon\/\">Epitalon<\/a> e <a href=\"https:\/\/medsbase.com\/it\/selank\/\">Selank<\/a> Ci\u00f2 che differenzia il tirzepatide dai precedenti peptidi a incretina singola \u00e8 il suo. <\/p>\n<h2>Meccanismo d'azione \u2014 Architettura del sonno, reattivit\u00e0 allo stress e neuroprotezione<\/h2>\n<p>What makes DSIP unusual among peptides is the breadth of effects documented for such a small, linear peptide without a clearly identified primary receptor. Published studies has mapped its activity across <strong>tre domini sovrapposti<\/strong>, ciascuno dei quali contribuisce al fenotipo osservato:<\/p>\n<ul>\n<li><strong>Modulazione dell'architettura del sonno \u2014 sonno a onde delta (sonno a onde lente)<\/strong> \u2014 DSIP increases the proportion of slow-wave (stage 3\u20134 \/ N3) sleep on quantitative EEG measurements in rodent, rabbit, and human studies without proportionally reducing REM sleep. The effect is most pronounced when DSIP is administered to subjects with fragmented or shortened sleep, suggesting the peptide acts as a homeostatic sleep-pressure modulator rather than a primary sedative. Importantly, DSIP does not directly increase total sleep time in non-sleep-deprived subjects \u2014 it reorganises sleep architecture toward higher SWS proportion.<\/li>\n<li><strong>Modulazione dell'asse HPA e della reattivit\u00e0 allo stress<\/strong> \u2014 Diversi studi pubblicati documentano l'attenuazione del rilascio di cortisolo e ACTH indotto dallo stress nei modelli di stress da contenzione nei roditori, insieme alla riduzione della segnalazione dell'ormone rilasciante la corticotropina (CRH) nell'ipotalamo. L'effetto tampone dello stress opera su una scala temporale pi\u00f9 lunga rispetto ai sedativi benzodiazepinici e non produce sedazione comportamentale acuta, suggerendo una modulazione del tono dell'asse HPA piuttosto che un'ansiolisi acuta.<\/li>\n<li><strong>Anti-nocicezione, neuroprotezione e anti-astinenza<\/strong> \u2014 DSIP shows analgesic effects in rodent thermal and chemical-nociception models, including opioid-naive subjects (suggesting non-opioid mechanism). Russian and Eastern European has documented attenuation of opioid and alcohol withdrawal syndromes in preclinical models. Neuroprotective effects against oxidative stress, ischaemia, and excitotoxicity have been reported but remain mechanistically less well characterised than the sleep architecture work.<\/li>\n<\/ul>\n<p>The receptor target for DSIP has not been definitively identified, which is unusual for a peptide with this much published behavioural data. Proposed mechanisms include GABA-A modulation, opioid-system crosstalk, and direct interaction with hypothalamic CRH neurons. The lack of an identified primary receptor combined with multiple documented effects suggests DSIP may act as a multimodal neuromodulator rather than a classical receptor agonist \u2014 a hypothesis that remains an active studies question in published peptide pharmacology. <\/p>\n<h2>Published Evidence<\/h2>\n<p>DSIP is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Sleep architecture and EEG studies<\/strong> \u2014 quantitative EEG spectral analysis, slow-wave sleep proportion, sleep fragmentation in rodent and human studies (Schoenenberger &amp; Monnier, PNAS 1977; Kovalzon &amp; Strekalova, Sleep Med Rev 2006)<\/li>\n<li><strong>Stress reactivity and HPA-axis studies<\/strong> \u2014 dinamiche del cortisolo e dell'ACTH, espressione del CRH, modelli di stress da contenzione e stress cronico lieve nei roditori<\/li>\n<li><strong>Withdrawal syndrome studies<\/strong> \u2014 gravit\u00e0 dell'astinenza da oppioidi, astinenza da alcol, riduzione graduale delle benzodiazepine; letteratura prevalentemente russa e dell'Europa orientale<\/li>\n<li><strong>Nociception and chronic pain studies<\/strong> \u2014 modelli di tail-flick, hot-plate, formalina e lesione da costrizione cronica nei roditori; caratterizzazione dei meccanismi non oppioidi<\/li>\n<li><strong>Neuroprotection studies<\/strong> \u2014 marcatori dello stress ossidativo, lesione da ischemia-riperfusione, modelli di eccitotossicit\u00e0<\/li>\n<li><strong>Circadian biology studies<\/strong> \u2014 entrainment, risposta allo spostamento di fase, modulazione del ritmo della melatonina e della temperatura corporea<\/li>\n<li><strong>Comparative sleep-axis peptide studies<\/strong> \u2014 benchmarking rispetto a <a href=\"https:\/\/medsbase.com\/it\/epitalon\/\">Epitalon<\/a> (tetrapeptide pineale) per gli effetti circadiani e rispetto a <a href=\"https:\/\/medsbase.com\/it\/selank\/\">Selank<\/a> per effetti di tamponamento dello stress senza sedazione.<\/li>\n<\/ul>\n<p>Per un contesto pi\u00f9 ampio su dove si colloca il DSIP nel panorama dei piccoli peptidi attivi sul SNC, vedere <a href=\"https:\/\/medsbase.com\/it\/epitalon\/\">Epitalon<\/a> (AEDG pineal tetrapeptide, circadian-axis studies), <a href=\"https:\/\/medsbase.com\/it\/selank\/\">Selank<\/a> (eptapeptide ansiolitico), e <a href=\"https:\/\/medsbase.com\/it\/semax\/\">Semax<\/a> (eptapeptide nootropo). Esplora l'intera gamma <a href=\"https:\/\/medsbase.com\/it\/peptides\/\">catalogo peptidi<\/a> per composti correlati. <\/p>\n<h2>Concentrazioni e Dosaggi Disponibili<\/h2>\n<p>MedsBase stocks DSIP in three lyophilized vial sizes covering pilot dosing through extended protocols. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosaggio per Flaconcino<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso d'Uso Tipico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dimensioni della Confezione<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing, single-EEG-session studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, multi-week sleep-architecture studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>15 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocolli a ciclo esteso, costo per mg pi\u00f9 basso, studi su coorti multiple<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection volume in rodent protocols or run extended studies from a single vial. <\/p>\n<h2>Confronto \u2014 DSIP vs Epitalon<\/h2>\n<p>DSIP e <a href=\"https:\/\/medsbase.com\/it\/epitalon\/\">Epitalon<\/a> are the two most-cited small peptides involved in sleep, circadian, and rest-state studies. They share several studies-relevant features \u2014 both are short, linear, unmodified peptides without identified primary receptors, and both produce phenotypic effects that outlast plasma clearance \u2014 but their primary signals are distinct: DSIP modulates sleep architecture directly via SWS proportion; Epitalon acts on the pineal-melatonin axis and circadian gene expression. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">DSIP<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epitalon<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lunghezza<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">9 aminoacidi (lineare)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">4 aminoacidi (tetrapeptide)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Sequenza<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">WAGGDASGE<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">AEDG (Ala-Glu-Asp-Gly)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Proporzione di sonno a onde lente (delta EEG)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Asse pineale-melatonina, telomerasi, espressione genica circadiana<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Recettore identificato<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nessuno (neuromodulatore multimodale)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nessuno (regolazione genica, intracellulare)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dosaggio tipico<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013500 mcg, 1 volta al giorno<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201310 mg, 1 volta al giorno per cicli<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Inizio dell'effetto<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nella stessa sessione (misurabile con EEG)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Multi-settimanale (scala temporale dell'espressione genica)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Stacking<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Co-administered with Epitalon in circadian-sleep stack studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Somministrato in combinazione con DSIP per effetti combinati su sonno e ritmi circadiani<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For sleep-architecture studies, DSIP is the canonical first choice because it produces measurable EEG-level effects on slow-wave sleep proportion within a single sleep session. For circadian-rhythm and gene-regulatory studies, Epitalon is preferred because the effect timescale matches the underlying biology (gene expression changes over days to weeks). The two are frequently co-administered when both axes are part of the studies question. <\/p>\n<h2>Conservazione e ricostituzione<\/h2>\n<p><strong>Prima della ricostituzione:<\/strong> Conservare i flaconcini liofilizzati refrigerati a 2\u20138\u00b0C nella confezione originale per scorte di lavoro a breve termine. Per lo stoccaggio a lungo termine non aperto, congelare a \u221220\u00b0C. Il DSIP liofilizzato \u00e8 stabile in refrigerazione fino a 24 mesi e a \u221220\u00b0C fino a 36 mesi. Evitare cicli di congelamento-scongelamento della polvere liofilizzata. Il DSIP \u00e8 igroscopico \u2014 richiudere prontamente i flaconcini dopo l'apertura e conservarli in un contenitore essiccato se disponibile. <strong>Procedura di ricostituzione:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 2.0\u00a0mL of bacteriostatic water yields a 2.5\u00a0mg\/mL working concentration \u2014 0.04\u00a0mL delivers a 100\u00a0mcg dose. Swirl gently \u2014 do <strong>not<\/strong> scuotere \u2014 e attendere 2\u20135 minuti per la completa dissoluzione. Una soluzione ricostituita correttamente dovrebbe essere chiara e incolore. <strong>Dopo la ricostituzione:<\/strong> Conservare in frigorifero a 2\u20138\u00b0C e utilizzare entro 30 giorni per una stabilit\u00e0 ottimale. Non congelare la soluzione ricostituita \u2014 i cicli di congelamento-scongelamento degradano l'integrit\u00e0 del peptide. Scartare qualsiasi flaconcino che presenti torbidit\u00e0, precipitato o scolorimento. <\/p>\n<h2 id=\"faqs\">Domande frequenti<\/h2>\n<h3>What is DSIP used for in studies?<\/h3>\n<p>DSIP is used in studies investigating sleep architecture (particularly slow-wave sleep proportion), HPA-axis and stress reactivity, opioid and alcohol withdrawal syndromes, non-opioid analgesia, neuroprotection, and circadian biology. It is the most-cited sleep-axis peptide that does not act primarily as a sedative \u2014 effects manifest as reorganisation of sleep architecture rather than increased total sleep time. The pharmaceutical-grade DSIP sold here is <strong>not<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>In cosa differisce il DSIP dall'Epitalon?<\/h3>\n<p>Both are small unmodified peptides without identified primary receptors that influence rest-state biology, but their primary signals differ. DSIP modulates sleep architecture at the EEG level \u2014 specifically increasing slow-wave sleep proportion within a single sleep session. Epitalon acts on the pineal-melatonin axis and circadian gene expression on a gene-expression timescale of days to weeks. The two are mechanistically complementary and frequently co-administered in studies investigating combined sleep and circadian endpoints. <\/p>\n<h3>What is the typical DSIP dose?<\/h3>\n<p>I protocolli preclinici pubblicati utilizzano tipicamente 100\u2013500 mcg per somministrazione in modelli roditori, somministrati per via sottocutanea o intraperitoneale una volta al giorno per cicli di 7\u201328 giorni. Una fiala da 5 mg ricostituita con 2,0 mL di acqua batteriostatica produce 2,5 mg\/mL \u2014 0,04 mL equivalgono a 100 mcg. <\/p>\n<h3>Il DSIP \u00e8 approvato dalla FDA?<\/h3>\n<p>No. DSIP is not approved by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. <\/p>\n<h3>Come dovrebbe essere conservato il DSIP?<\/h3>\n<p>Fiale liofilizzate: refrigerate a 2\u20138 \u00b0C per scorte di lavoro a breve termine, o a \u221220 \u00b0C per lo stoccaggio a lungo termine di fiale non aperte. Il DSIP \u00e8 igroscopico \u2014 richiudere le fiale prontamente dopo l'apertura. Soluzione ricostituita: refrigerata a 2\u20138 \u00b0C, utilizzare entro 30 giorni. Non congelare la soluzione ricostituita \u2014 i cicli di congelamento-scongelamento degradano il peptide. Proteggere dalla luce diretta in ogni momento. <\/p>\n<h3>Come si ricostituisce il DSIP?<\/h3>\n<p>Seguire la procedura di ricostituzione sopra indicata. Aggiungere acqua batteriostatica lungo la parete laterale del flaconcino (non direttamente sulla polvere liofilizzata), agitare delicatamente e attendere 2-5 minuti per la completa dissoluzione. Non <strong>not<\/strong> Agitare la fiala. Una soluzione correttamente ricostituita \u00e8 chiara e incolore. Per una fiala da 5 mg + 2,0 mL di diluente, la concentrazione di lavoro \u00e8 2,5 mg\/mL. <\/p>\n<h3>Quali dosaggi sono disponibili su MedsBase?<\/h3>\n<p>MedsBase carries DSIP in 5\u00a0mg, 10\u00a0mg, and 15\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Does DSIP cause sedation in study models?<\/h3>\n<p>No \u2014 this is one of the most-cited findings in DSIP studies. Unlike benzodiazepines or other classical sedatives, DSIP does not produce acute behavioural sedation, motor coordination loss, or impaired alertness. Instead it modulates sleep architecture toward a higher proportion of slow-wave sleep when the subject does sleep, without increasing total sleep time in non-sleep-deprived subjects. This distinct profile is one of the reasons DSIP has remained a compound rather than a clinical sedative. <\/p>\n<h3>Can DSIP and Epitalon be stacked in studies?<\/h3>\n<p>Yes. DSIP and Epitalon act on different timescales and biological compartments (acute EEG-level sleep architecture vs gene-expression-level circadian regulation), so co-administration is not pharmacologically redundant. Study protocols studying combined sleep-quality and circadian-rhythm endpoints frequently use both peptides. <\/p>\n<h3>Does DSIP cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation. Long-term human safety data is limited because the peptide has not undergone modern Western regulatory review. The small size and lack of identified primary receptor are consistent with the clean tolerability profile. <\/p>\n<h3>Qual \u00e8 l'emivita del DSIP?<\/h3>\n<p>In preclinical studies, DSIP has a plasma half-life of approximately 7\u201315 minutes following intravenous or subcutaneous administration. The short plasma half-life is offset by the peptide&#8217;s ability to cross the blood-brain barrier and produce effects on sleep architecture and gene expression that persist well beyond plasma clearance. <\/p>\n<h3>Perch\u00e9 il DSIP \u00e8 stato originariamente isolato?<\/h3>\n<p>Il DSIP \u00e8 stato identificato nel 1977 da Schoenenberger e Monnier all'Universit\u00e0 di Basilea dializzando il sangue venoso cerebrale di conigli durante la stimolazione elettrica del talamo intralaminare \u2014 una regione cerebrale nota per indurre il sonno a onde delta (sonno a onde lente). Hanno concentrato la frazione bioattiva e caratterizzato il peptide che produceva l'effetto pi\u00f9 marcato sull'EEG del sonno quando trasferito ad animali riceventi. Il peptide \u00e8 stato nominato per la sua firma elettroencefalografica dominante: aumento dell'attivit\u00e0 a onde delta durante il sonno. <\/p>\n<h3>How long does DSIP take to show effects in preclinical studies?<\/h3>\n<p>Gli effetti acuti sull'architettura del sonno e sulla proporzione di onde delta nell'EEG sono rilevabili gi\u00e0 nella prima sessione di sonno successiva alla somministrazione. Gli effetti sull'asse HPA e sulla reattivit\u00e0 allo stress si accumulano in 7-14 giorni di somministrazione regolare. Gli effetti anti-astinenza nei modelli di astinenza da oppioidi e alcol sono tipicamente misurati in periodi di astinenza di 3-7 giorni. <\/p>\n<h3>Posso ordinare DSIP per la spedizione internazionale?<\/h3>\n<p>S\u00ec. MedsBase spedisce DSIP in tutto il mondo dalla nostra rete dedicata di spedizione di peptidi. Gli ordini contenenti solo peptidi si qualificano per il nostro servizio di spedizione dedicato. Tutti gli ordini vengono spediti in imballaggi a temperatura controllata con tracciamento completo e sono coperti dalla nostra <a href=\"https:\/\/medsbase.com\/it\/medsbase-re-shipment-assurance-policy\/\">Politica di Garanzia di Rispedizione<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Sleep, Circadian, and CNS Studies<\/h2>\n<ul>\n<li><a href=\"\/it\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 pineal-melatonin axis and circadian gene-expression studies<\/li>\n<li><a href=\"\/it\/selank\/\"><strong>Selank<\/strong><\/a> \u2014 Anxiolytic heptapeptide tuftsin analog \u2014 GABA\/BDNF stress resilience<\/li>\n<li><a href=\"\/it\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Eptapeptide nootropo sviluppato in Russia \u2014 modulazione melanocortinica e dopaminergica<\/li>\n<li><a href=\"\/it\/oxytocin-acetate\/\"><strong>Ossitocina Acetato<\/strong><\/a> \u2014 9-aa cyclic nonapeptide \u2014 social-bonding and affiliative behavioural support<\/li>\n<li><a href=\"\/it\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 healing and tissue-recovery<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Approfondimenti<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore sleep, circadian, and CNS peptides<\/strong><\/p>\n<p style=\"margin: 0;\">Sfoglia l'intera <a href=\"https:\/\/medsbase.com\/it\/peptides\/\"><strong>catalogo peptidi<\/strong><\/a>, con composti correlati tra cui <a href=\"https:\/\/medsbase.com\/it\/epitalon\/\">Epitalon<\/a> for circadian gene-expression studies, <a href=\"https:\/\/medsbase.com\/it\/selank\/\">Selank<\/a> for anxiolytic stress-axis studies, and <a href=\"https:\/\/medsbase.com\/it\/oxytocin-acetate\/\">Ossitocina Acetato<\/a> for social-bonding behavioural support.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Peptide Induttore del Sonno Delta (scoperto nel 1977)<br \/>\n\u2705 Modula l'architettura del sonno a onde lente<br \/>\n\u2705 HPA-axis stress reactivity<br \/>\n\u2705 Effetto anti-astinenza e analgesia non oppioide<br \/>\n\u2705 Attraversa la barriera emato-encefalica<\/p>\n<p><strong>DSIP<\/strong> contiene composto peptidico sintetico.<\/p>","protected":false},"featured_media":70946,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6275,5441],"class_list":["post-70711","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-dsip","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product\/70711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/comments?post=70711"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media\/70946"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media?parent=70711"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_brand?post=70711"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_cat?post=70711"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_tag?post=70711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}